Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Brain tumors

  • You have access
    Correlation of intratumor textual heterogeneity on 4’-[methyl-11C]thiothymidine PET/CT with Ki-67 immunohistochemistry and tumor grade in patients with newly diagnosed gliomas
    Yuka Yamamoto, Katsuya Mitamura, Yukito Maeda, Tetsuhiro Hatakeyama, Hiroyuki Yamamoto, Nobuyuki Kudomi, Jun Toyohara and Yoshihiro Nishiyama
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 185;
  • You have access
    Imaging of tumor-associated system xC- activity with 18F-fluoropropylglutamate (18F-FSPG) PET/CT for intracranial malignancies
    Ida Sonni, Ryogo Minamimoto, Mehran Jamali, Negin Hatami, Mathias Berndt, Norman Koglin, Andrew Stephens, Andrei Iagaru, Frederick Chin, Sanjiv Gambhir and Erik Mittra
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 181;
  • You have access
    Texture analysis of 11C-Methionine PET may help glioma grading
    Kentaro Kobayashi, Kenji Hirata, Shigeru Yamaguchi, Hiroyuki Kobayashi, Shunsuke Terasaka, Osamu Manabe, TAKUYA TOYONAGA, Yuko Uchiyama, Shiro Watanabe, Hisaya Kikuchi, Tohru Shiga and Nagara Tamaki
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 179;
  • You have access
    18F-fluoromisonidazole uptake in metastatic brain lesions may predict time-to-progression after radiation therapy.
    TAKUYA TOYONAGA, Takashi Mori, Osamu Manabe, Kenji Hirata, Rikiya Onimaru, Koichi Yasuda, Shigeru Yamaguchi, Kentaro Kobayashi, Shiro Watanabe, Tohru Shiga, Yuji Kuge, Ken-ichi Nishijima, Hiroki Shirato and Nagara Tamaki
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 180;
  • You have access
    The Prognostic Value of O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography (FET-PET) at Radiotherapy Planning in Newly Diagnosed Glioblastoma
    Sidsel Poulsen, Thomas Urup, Kirsten Grunnet, Ib Christensen, Vibeke Larsen, Rosenschold Per, Hans Poulsen and Ian Law
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 182;
  • You have access
    Intra- and inter-dividual correlation of simultaneously acquired 18F-fluorethyltyrosine PET and perfusion MRI parameters in patients with untreated glioma
    Thomas Pyka, Jens Göttler, Mathias Lukas, Anne Kluge, Jens Gempt, Florian Ringel, Claus Zimmer, Markus Schwaiger, Stefan Förster and Christine Preibisch
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 184;
  • You have access
    Serial 18F-FET PET of primarily 18F-FET-negative glioma - does it make sense?
    Marcus Unterrainer, Florian Schweisthal, Bogdana Suchorska, Vera Wenter, Christine Schmid-Tannwald, Wolfgang Fendler, Ulrich Schüller, Jörg-Christian Tonn, Peter Bartenstein and Nathalie Albert
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 183;
  • You have access
    A pilot study on imaging of integrin αvβ3 with RGD PET/CT in patients with glioma
    Ning Liu, Wei Zhao, Xu-Dong Hu, Song Gao, Qingxi Yu, Suzhen Wang, Wenhong Hou, Shouhui Zhu, Hong Lu and Shuanghu Yuan
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 324;
  • You have access
    ACRIN 6684: Multicenter phase II assessment of tumor hypoxia in glioblastoma using 18F-Fluoromisonidazole (FMISO) PET and MRI
    James Fink, Zheng Zhang, Gertstner Elizabeth, Mark Muzi, Lale Kostakoglu, Akiva Mintz, Edward Eikmann, Daniel Barboriak and David Mankoff
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 325;
  • You have access
    Co-analysis of textural pattern and SUVpeak in F18-FDOPA PET/CT significantly improves glioma staging
    Christophe Nioche, Fanny Orlhac, Marine Soret, Eric Gontier and Irene Buvat
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 327;

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
SNMMI

© 2025 SNMMI

Powered by HighWire